IRIDEX Corporation (IRIX) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
IRIDEX Corporation (IRIX) Bundle
Explore the financial prospects of IRIDEX Corporation (IRIX) with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and expenses to calculate the intrinsic value of IRIDEX Corporation (IRIX) and enhance your investment strategy.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.4 | 36.3 | 53.9 | 57.0 | 51.9 | 55.6 | 59.6 | 63.9 | 68.4 | 73.3 |
| Revenue Growth, % | 0 | -16.34 | 48.3 | 5.69 | -8.96 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 |
| EBITDA | -8.3 | -6.1 | -6.7 | -6.1 | -8.0 | -8.3 | -8.9 | -9.5 | -10.2 | -10.9 |
| EBITDA, % | -19.07 | -16.72 | -12.49 | -10.7 | -15.38 | -14.87 | -14.87 | -14.87 | -14.87 | -14.87 |
| Depreciation | .7 | .5 | .8 | 1.4 | 2.0 | 1.2 | 1.3 | 1.4 | 1.5 | 1.6 |
| Depreciation, % | 1.58 | 1.39 | 1.49 | 2.43 | 3.92 | 2.16 | 2.16 | 2.16 | 2.16 | 2.16 |
| EBIT | -9.0 | -6.6 | -7.5 | -7.5 | -10.0 | -9.5 | -10.1 | -10.9 | -11.7 | -12.5 |
| EBIT, % | -20.66 | -18.11 | -13.98 | -13.13 | -19.29 | -17.03 | -17.03 | -17.03 | -17.03 | -17.03 |
| Total Cash | 12.7 | 11.6 | 23.9 | 13.9 | 7.0 | 15.9 | 17.1 | 18.3 | 19.6 | 21.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 9.3 | 7.3 | 9.7 | 9.8 | 9.7 | 10.6 | 11.4 | 12.2 | 13.0 | 14.0 |
| Account Receivables, % | 21.46 | 20.05 | 18.02 | 17.15 | 18.61 | 19.06 | 19.06 | 19.06 | 19.06 | 19.06 |
| Inventories | 8.2 | 5.7 | 7.6 | 10.6 | 9.9 | 9.6 | 10.3 | 11.0 | 11.8 | 12.7 |
| Inventories, % | 18.81 | 15.72 | 14.13 | 18.62 | 19.1 | 17.28 | 17.28 | 17.28 | 17.28 | 17.28 |
| Accounts Payable | 2.6 | 1.1 | 2.8 | 3.9 | 4.5 | 3.3 | 3.5 | 3.8 | 4.1 | 4.4 |
| Accounts Payable, % | 5.97 | 3.16 | 5.14 | 6.77 | 8.67 | 5.94 | 5.94 | 5.94 | 5.94 | 5.94 |
| Capital Expenditure | -.1 | -.1 | -.2 | -.3 | -.1 | -.2 | -.2 | -.2 | -.2 | -.2 |
| Capital Expenditure, % | -0.29461 | -0.26687 | -0.39515 | -0.502 | -0.21014 | -0.33376 | -0.33376 | -0.33376 | -0.33376 | -0.33376 |
| Tax Rate, % | -0.94937 | -0.94937 | -0.94937 | -0.94937 | -0.94937 | -0.94937 | -0.94937 | -0.94937 | -0.94937 | -0.94937 |
| EBITAT | -9.0 | -6.6 | -7.6 | -7.5 | -10.1 | -9.5 | -10.1 | -10.9 | -11.7 | -12.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -23.4 | -3.2 | -9.7 | -8.4 | -6.7 | -10.3 | -10.3 | -11.0 | -11.8 | -12.6 |
| WACC, % | 7.92 | 7.92 | 7.92 | 7.92 | 7.92 | 7.92 | 7.92 | 7.92 | 7.92 | 7.92 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -44.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -13 | |||||||||
| Terminal Value | -218 | |||||||||
| Present Terminal Value | -149 | |||||||||
| Enterprise Value | -193 | |||||||||
| Net Debt | -4 | |||||||||
| Equity Value | -189 | |||||||||
| Diluted Shares Outstanding, MM | 16 | |||||||||
| Equity Value Per Share | -11.71 |
What You Will Get
- Real IRIDEX Financial Data: Pre-filled with IRIDEX Corporation’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See IRIDEX's intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive IRIDEX Data: Pre-loaded with IRIDEX Corporation's historical performance metrics and future growth estimates.
- Customizable Assumptions: Modify parameters such as revenue growth rates, profit margins, discount rates, tax obligations, and capital investments.
- Interactive Valuation Framework: Real-time adjustments to Net Present Value (NPV) and intrinsic value based on user-defined inputs.
- Multiple Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation results.
- Intuitive User Interface: Clean, organized design suitable for both seasoned professionals and newcomers.
How It Works
- Step 1: Download the prebuilt Excel template featuring IRIDEX Corporation's (IRIX) data.
- Step 2: Examine the pre-filled sheets to grasp the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the recalculated results, including IRIDEX Corporation's (IRIX) intrinsic value.
- Step 5: Make well-informed investment decisions or create reports based on the outputs.
Why Choose IRIDEX Corporation (IRIX)?
- Innovative Solutions: Cutting-edge technology designed to enhance patient care and outcomes.
- Proven Track Record: Established history of delivering reliable and effective medical devices.
- Commitment to Quality: Rigorous standards ensure the highest level of product performance and safety.
- Expert Support: Dedicated customer service team ready to assist with any inquiries or challenges.
- Industry Recognition: A trusted name among healthcare professionals and institutions worldwide.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for analyzing portfolios involving IRIDEX Corporation (IRIX).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights to clients interested in investing in IRIDEX Corporation (IRIX).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling related to IRIDEX Corporation (IRIX).
- Tech Enthusiasts: Gain insights into the market valuation of tech firms like IRIDEX Corporation (IRIX).
What the Template Contains
- Pre-Filled Data: Includes IRIDEX Corporation's historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze IRIDEX Corporation's profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.